AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
The U.S. FDA has given the green light for AstraZeneca's FluMist nasal spray vaccine to be self-administered or administered ...
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or ...
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's influenza nasal spray vaccine for ...
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...
(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US. The Cambridge, England-based biopharmaceutical company ...
FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.